ICON plc - stock earnings
ICLR Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 25, 2024 AfterMarket | 3.47 / 3.48 | 2.1 billion | - / 2.1 billion | 2.1 billion |
| July 24, 2024 BeforeMarket | - / - | 2.1 billion | - / 2.1 billion | 2.2 billion |
ICLR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 187.4 million USD | 2.1 billion USD |
| 2023Q4 | 216.4 million USD | 2.1 billion USD |
| 2023Q3 | 163.7 million USD | 2.1 billion USD |
| 2023Q2 | 115.6 million USD | 2.0 billion USD |
| 2023Q1 | 116.7 million USD | 2.0 billion USD |
| 2022Q4 | 117.4 million USD | 2.0 billion USD |
| 2022Q3 | 160.2 million USD | 1.9 billion USD |
| 2022Q2 | 115.7 million USD | 1.9 billion USD |
| 2022Q1 | 112.0 million USD | 1.9 billion USD |
| 2021Q4 | 76.5 million USD | 1.9 billion USD |
| 2021Q3 | -94.3 million USD | 1.9 billion USD |
| 2021Q2 | 73.9 million USD | 871.2 million USD |
| 2021Q1 | 97.1 million USD | 858.2 million USD |
| 2020Q4 | 101.2 million USD | 760.2 million USD |
| 2020Q3 | 91.6 million USD | 701.7 million USD |
| 2020Q2 | 47.8 million USD | 620.2 million USD |
| 2020Q1 | 91.7 million USD | 715.1 million USD |
| 2019Q4 | 99.0 million USD | 725.4 million USD |
| 2019Q3 | 94.8 million USD | 710.4 million USD |
| 2019Q2 | 91.9 million USD | 695.1 million USD |
| 2019Q1 | 88.3 million USD | 674.9 million USD |
| 2018Q4 | 88.2 million USD | 679.0 million USD |
| 2018Q3 | 84.5 million USD | 655.0 million USD |
| 2018Q2 | 71.9 million USD | 641.6 million USD |
| 2018Q1 | 78.1 million USD | 620.1 million USD |
| 2017Q4 | 71.1 million USD | 455.1 million USD |
| 2017Q3 | 74.2 million USD | 440.3 million USD |
| 2017Q2 | 64.8 million USD | 431.0 million USD |
| 2017Q1 | 71.4 million USD | 432.0 million USD |
| 2016Q4 | 74.3 million USD | 435.1 million USD |
| 2016Q3 | 63.9 million USD | 420.2 million USD |
| 2016Q2 | 61.1 million USD | 410.6 million USD |
| 2016Q1 | 63.0 million USD | 400.5 million USD |
| 2015Q4 | 63.4 million USD | 403.3 million USD |
| 2015Q3 | 61.5 million USD | 394.7 million USD |
| 2015Q2 | 58.6 million USD | 388.7 million USD |
| 2015Q1 | 55.9 million USD | 388.2 million USD |
| 2014Q4 | 45.2 million USD | 390.1 million USD |
| 2014Q3 | 50.3 million USD | 387.6 million USD |
| 2014Q2 | 40.8 million USD | 376.0 million USD |
| 2014Q1 | 36.2 million USD | 349.6 million USD |
| 2013Q4 | 33.5 million USD | 345.2 million USD |
| 2013Q3 | 27.8 million USD | 339.8 million USD |
| 2013Q2 | 22.5 million USD | 334.2 million USD |
| 2013Q1 | 19.0 million USD | 316.8 million USD |
| 2012Q4 | 20.7 million USD | 300.2 million USD |
| 2012Q3 | 17.7 million USD | 285.5 million USD |
| 2012Q2 | 8.0 million USD | 277.0 million USD |
| 2012Q1 | 9.0 million USD | 252.3 million USD |
| 2011Q4 | 4.1 million USD | 242.6 million USD |
| 2011Q3 | -2.7 million USD | 240.8 million USD |
| 2011Q2 | 13.1 million USD | 233.0 million USD |
| 2011Q1 | 8.3 million USD | 229.3 million USD |
| 2010Q4 | 22.1 million USD | 232.1 million USD |
| 2010Q3 | 19.9 million USD | 225.1 million USD |
| 2010Q2 | 22.9 million USD | 223.8 million USD |
| 2010Q1 | 22.2 million USD | 219.1 million USD |
| 2009Q4 | 30.9 million USD | 227.4 million USD |
| 2009Q3 | 24.0 million USD | 220.4 million USD |
| 2009Q2 | 22.8 million USD | 220.0 million USD |
| 2009Q1 | 20.9 million USD | 219.8 million USD |
| 2008Q4 | 21.0 million USD | 220.1 million USD |
| 2008Q3 | 21.4 million USD | 225.5 million USD |
| 2008Q2 | 18.8 million USD | 218.3 million USD |
| 2008Q1 | 15.9 million USD | 180.7 million USD |
| 2007Q4 | 15.9 million USD | 180.7 million USD |
| 2007Q3 | 14.5 million USD | 166.9 million USD |
| 2007Q2 | 13.3 million USD | 147.0 million USD |
| 2007Q1 | 12.3 million USD | 136.1 million USD |
| 2006Q4 | 11.4 million USD | 129.0 million USD |
| 2006Q3 | 10.1 million USD | 120.7 million USD |
| 2006Q2 | 9.3 million USD | 107.4 million USD |
| 2006Q1 | 7.5 million USD | 98.5 million USD |
| 2005Q4 | 465000 USD | 113.9 million USD |
| 2005Q3 | 7.0 million USD | 88.1 million USD |
| 2005Q2 | 6.4 million USD | 85.9 million USD |
| 2005Q1 | 5.9 million USD | 86.0 million USD |
| 2004Q4 | -5.5 million USD | 82.9 million USD |
| 2004Q3 | 5.8 million USD | 79.5 million USD |
| 2004Q2 | 7.3 million USD | 78.3 million USD |
| 2004Q1 | 7.2 million USD | 77.9 million USD |
| 2003Q4 | 6.7 million USD | 76.9 million USD |
| 2003Q3 | 6.3 million USD | 73.2 million USD |
| 2003Q2 | 5.6 million USD | 68.9 million USD |
| 2003Q1 | 5.3 million USD | 66.0 million USD |
| 2002Q4 | 4.6 million USD | 59.3 million USD |
| 2002Q3 | 4.4 million USD | 53.5 million USD |
| 2002Q2 | 4.0 million USD | 46.9 million USD |
| 2002Q1 | 3.8 million USD | 43.0 million USD |
| 2001Q4 | 3.6 million USD | 39.6 million USD |
| 2001Q3 | 3.5 million USD | 37.8 million USD |
| 2001Q2 | 3.3 million USD | 36.2 million USD |
| 2001Q1 | 3.1 million USD | 31.5 million USD |
| 2000Q4 | 2.8 million USD | 29.7 million USD |
| 2000Q3 | 2.7 million USD | 28.6 million USD |
| 2000Q2 | 2.5 million USD | 26.3 million USD |
| 2000Q1 | 2.3 million USD | 22.4 million USD |
| 1999Q4 | 12000 USD | 20.7 million USD |
| 1999Q3 | 1.9 million USD | 17.9 million USD |
| 1999Q2 | 1.6 million USD | 17.0 million USD |
| 1999Q1 | 1.6 million USD | 14.5 million USD |
| 1998Q4 | 2.1 million USD | 14.7 million USD |
| 1998Q3 | 1.9 million USD | 13.7 million USD |
| 1998Q2 | 1.9 million USD | 12.8 million USD |
| 1998Q1 | 1.2 million USD | 12.1 million USD |
| 1997Q4 | 900000 USD | 10.0 million USD |
| 1997Q3 | 900000 USD | 10.0 million USD |
| 1997Q2 | 900000 USD | 10.0 million USD |
ICLR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 612.3 million USD | 8.1 billion USD |
| 2022 | 505.3 million USD | 7.7 billion USD |
| 2021 | 153.2 million USD | 5.5 billion USD |
| 2020 | 327.8 million USD | 2.8 billion USD |
| 2019 | 374.0 million USD | 2.8 billion USD |
| 2018 | 322.8 million USD | 2.6 billion USD |
| 2017 | 272.9 million USD | 1.8 billion USD |
| 2016 | 262.2 million USD | 1.7 billion USD |
| 2015 | 239.5 million USD | 1.6 billion USD |
| 2014 | 172.5 million USD | 1.5 billion USD |
| 2013 | 102.8 million USD | 1.3 billion USD |
| 2012 | 58.3 million USD | 1.1 billion USD |
| 2011 | 22.9 million USD | 945.7 million USD |
| 2010 | 87.1 million USD | 900.0 million USD |
| 2009 | 94.3 million USD | 887.6 million USD |
| 2008 | 78.1 million USD | 865.2 million USD |
| 2007 | 56.0 million USD | 630.7 million USD |
| 2006 | 38.3 million USD | 455.6 million USD |
| 2005 | 7.4 million USD | 202.0 million USD |
| 2004 | 25.7 million USD | 296.9 million USD |
| 2003 | 18.3 million USD | 225.7 million USD |
| 2002 | 18.3 million USD | 225.7 million USD |
| 2001 | 14.2 million USD | 156.6 million USD |
| 2000 | 11.0 million USD | 116.2 million USD |
| 1999 | 6.1 million USD | 80.8 million USD |
| 1998 | 7.5 million USD | 55.8 million USD |
| 1997 | 3.9 million USD | 42.1 million USD |
ICLR
Price: $305.03
52 week price:
Earnings Per Share: 7.41 USD
P/E Ratio: 46.59
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 457160
Ebitda: 105.9 millionMarket Capitalization: 24.6 billion